Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Rather than pursuing unproven combinations of investigational and licensed agents, patients are encouraged to: Engage with NHS weight management services , which offer multidisciplinary support including dietary advice, behavioural therapy, and pharmacotherapy where appropriate including orlistat and, where eligible, GLP-1-based medicines Discuss licensed options with their GP if they meet eligibility criteria, including referral pathways for bariatric surgery in line with NICE obesity guidance Participate in clinical trials if interested in investigational agents such as retatrutide, through legitimate research pathways listed on the NIHR Clinical Research Network or ClinicalTrials.gov The safest and most effective treatments are those supported by robust clinical evidence, prescribed by qualified clinicians, and obtained through regulated supply chains
Nature Reviews Endocrinology , 5(7), 374381
Investigational options belong in clinical trials or future regulatory review
10.1056/NEJMoa003417 85 von ScholtenB
others price flat
JAMA Network Open, 6(5), e2314493
US$ 24.80
US$ 26.91
US$ 29.60
